|Publication status||Published - 20 May 2014|
A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.
E.K.S. Lim, M.B. Freidin, D.V. Freydina, D. Chudasama, M. Leung, S. Popat, D.G. de Castro, A. Rice, V. Anikin, A.M. Fernandez, A.G. Nicholson
Research output: Contribution to conference › Other › peer-review